Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Cornea / Ocular Surface, Health Economics and Policy

The Route to K-MAP

Establishing the actual prevalence of keratoconus is important for many reasons, not least because the allocation of public funds to healthcare activities, such as screening programs, is influenced by such data. And effective screening is essential if we are to diagnose patients sufficiently early to preserve vision with procedures such as corneal cross-linking (CXL). But what is the current situation regarding estimates of keratoconus prevalence?

Read the full article now

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Authors

Emilio de Almeida Torres-Netto

Emilio de Almeida Torres-Netto is currently completing a PhD and Research Fellowship at the Federal University of São Paulo, Brazil, in association with the University of Zurich, Switzerland.


Nikki-Hafezi

Nikki Hafezi

Nikki Hafezi is the Managing Director and CEO of GroupAdvance Consulting and EMAGine SA, which provide business development and fundraising advice to companies in the medical technology field, and develop, manufacture and market medical products to address unmet ophthalmic needs. She is also in charge of business strategy and development at the ELZA institute, a new eye hospital and research center in Zurich. Her current focus is translating CXL technology to treat infectious keratitis into clinical applications

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register